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Abstract
In schizophrenia, neurocognition, social cognition and functional outcome are all inter-related,
with social cognition mediating the impact that impaired neurocognition has on functional
outcome. Less clear is the nature of the relationship between neurocognition, social cognition and
functional outcome in individuals at clinical high risk (CHR) for psychosis. 137 CHR participants
completed a neurocognitive test battery, a battery of social cognition tasks and the Social
Functioning Scale. Confirmatory factor analysis showed that all social cognition tasks were
reliable and valid measures of the latent variable. The path from neurocognition to functioning
was statistically significant (standardized coefficient β = 0.22, p <0.01). The path from social
cognition to functioning was also statistically significant (β= 0.27, p<0.05). In the mediation
model the bootstrapping estimate revealed a nonsignificant indirect effect that was the association
of social cognition with neurocognition and with functional outcome (β =0.20, 95% CI =−0.07 to
0.52, p=0.11). However, social cognition was significantly associated with neurocognition (β =
0.80, p < 0.001) and the path from neurocognition to functioning was no longer significant as soon
as the mediator (social cognition) was entered into the mediation model (β = 0.02, p = 0.92). All of
the model fit indices were very good. Unlike what has been observed with psychotic patients,
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social cognition does not seem to mediate the pathway from neurocognition to functional outcome
when assessed with a measure of social attainment in individuals at CHR for psychosis.
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1. Introduction
It is well established that individuals with schizophrenia at all stages of the illness evidence
deficits in neurocognition, social cognition, and functional outcome (Keefe and Harvey,
2012; Green et al., 2012). In particular, poor functional outcome tends to persist even when
symptoms are in remission (Tandon et al., 2010). Thus, to ultimately achieve recovery, it is
necessary to understand its key determinants and to direct rehabilitation efforts to factors
that may contribute to improved functioning.
Many studies have highlighted links between neurocognition, social cognition and
functional outcome at both the first episode of psychosis as well as for individuals who are
experiencing a more chronic course of illness (e.g. Allott et al., 2011; Fett et al., 2011).
Using sophisticated modelling techniques, several of these studies have demonstrated a
mediational role for social cognition (e.g. Addington et al., 2006b; Addington et al., 2010;
Schmidt et al., 2011). Furthermore, in these models social cognition is more proximal to
outcome than is neurocognition, that is, the average amount of variance in outcome
explained by social cognition is usually greater than the variance explained by
neurocognition (Fett et al., 2011). Understanding this relationship may be important for
planning targeted interventions. In fact growing attention is being given to the development
of new treatments specifically focused on cognitive (e.g. Wykes et al., 2011) or social
cognitive training (e.g. Horan et al., 2008) with encouraging preliminary results.
Recent progress in risk identification methodology has made it possible to identify
individuals who are putatively prodromal for psychosis, that is at clinical high risk (CHR) of
developing psychosis (McGlashan et al., 2010). It has been consistently reported that similar
or less severe deficits in neurocognition, social cognition and functional outcome are
observed in CHR individuals when compared to individuals at either their first episode or
those who have a more chronic course of illness (Addington and Barbato, 2012; Thompson
et al., 2011; Addington et al., 2008; Fusar-Poli et al., 2012b; Green et al., 2012). Although
deficits in neurocognition (Fusar-Poli et al., 2012b) may play a role in predicting transition
to psychosis in individuals at CHR, only one study to date has demonstrated that a
combination of neurocognitive tasks and social cognition assessed by a theory of mind task
was related to conversion (Kim et al., 2011). However, the associations amongst social
cognition, neurocognition and functional outcome have never been assessed in CHR
individuals. Examining if social cognition does mediate between neurocognition and
functional outcome at this stage of risk may add to our understanding of the development of
psychosis. In terms of prevention, CHR individuals represent a unique opportunity to
intervene early and possibly delay or prevent illness progression. Although only about one
third of individuals at CHR will develop psychosis, the remaining two thirds will most likely
continue to have poor functional outcome (Addington et al., 2011), and thus may benefit
from more effective treatment intervention as well. Therefore, an improved understanding of
the role of these early deficits in cognition and social cognition could be essential to
intervening with respect to functional outcome.
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Thus, based on the fact that a) a mediation role for social cognition has been observed at
both the first episode and later stages of psychosis; b) deficits in social cognition,
neurocognition and functional outcome are relatively stable across phases of the illness
including both the acute and remission phase; and c) CHR individuals as a group experience
similar deficits in neurocognition, social cognition and functional outcome, we predict that
social cognition will play a mediation role in the CHR population. The specific aim of this
study is, using Structural Equation Modeling (SEM), to verify if social cognition has a
mediating role between neurocognition and functioning. To our knowledge this is the first
study that attempted to verify this model in CHR individuals.
2. Method
2.1. Sample
The sample consisted of 137 (81 males, 56 females) individuals at CHR of psychosis. All of
the participants were part of a multi-site NIMH funded study called “Enhancing the
Prospective Prediction of Psychosis” (PREDICT). This was a 2-year longitudinal study
conducted at the University of Toronto, the University of North Carolina (UNC), and Yale
University to determine predictors of conversion in individuals at CHR of developing
psychosis; 57 were recruited at Toronto, 55 at UNC and 25 at Yale. All participants met the
Criteria of Prodromal Syndromes (COPS) based on the Structured Interview for Prodromal
Syndromes (SIPS) (McGlashan et al., 2010). One-hundred and thirty-six CHR participants
met attenuated positive symptom syndrome (APSS) criteria, which includes the emergence
or worsening of a non-psychotic level disturbance in thought content, thought process or
perceptual abnormality over the past year, and one participant met criteria for genetic risk
and deterioration (GRD), which required either a first degree relative with a psychotic
disorder or the subject having schizotypal personality disorder (SPD) plus at least a 30%
drop in functioning on the General Assessment of Functioning (GAF) scale in the past 12
months. Participants were excluded if they met criteria for any current or lifetime axis I
psychotic disorder, prior history of treatment with an antipsychotic, IQ< than 70, or past or
current history of a clinically significant central nervous system disorder that may confound
or contribute to clinical high risk symptoms. Participants were excluded if they were using
antipsychotics at baseline. Furthermore, antipsychotics were not used at any later points in
this study.
2.2. Measures
Criteria for a prodromal syndrome were determined using the Structured Interview for
Prodromal Syndromes (SIPS) (McGlashan et al., 2010). Symptoms were assessed with the
Scale of Prodromal Symptoms (SOPS), which consists of 19 items in 4 symptom domains:
positive, negative, general, and disorganized.
2.2.1. Neurocognition—Neurocognitive tests were chosen on the basis of their
demonstrated reliability, ability to discriminate patients with schizophrenia from healthy
participants, lack of ceiling and floor effects in a CHR population, and appropriateness for
individuals as young as 14 years of age. When available, age appropriate test versions were
used, and raw scores were converted to age matched standard scores where appropriate. Our
sample included participants younger than 14 (12–13). Therefore, we re-analyzed the data
without the 12–13 year old participants and the results did not change. The neurocognitive
tests battery included: Controlled Oral Word Association Test (COWAT), Category
Instances, Trail Making Test A and B, Stroop Test (Color Naming and Color-Word), Finger
Oscillation Test, Wisconsin Card Sorting Test (WCST), Ray Auditory Verbal Learning Test
(RAVLT), Computerized Test of Visuospatial Working Memory, N-back task, Letter
Number Sequencing Test, Continuous Performance Test – Identical Pairs (CPT-IP), and
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Digit Span Distractibility. These tests covered the neurocognitive domains of verbal fluency,
processing speed, motor function, executive function, verbal memory, verbal and spatial
working memory, and attention. This study was designed prior to the MATRICS battery but
our battery is very similar with the CPT-IP and the TMT A being common to both.
2.2.2. Social cognition—Measures of social cognition included: the Facial Emotion
Identification Test (FEIT), the Facial Emotion Discrimination Test (FEDT) (Kerr and Neale,
1993), and Affective prosody (AP) (Edwards et al., 2001), to assess affect processing, and
the “Reading the Mind in the Eyes” task (Baron-Cohen et al., 2001) to assess theory of
mind.
2.2.3. Functional outcome—Functional outcome was assessed using the Social
Functioning Scale (SFS), a self-report questionnaire that has excellent psychometric
properties (Birchwood et al., 1990). The SFS has a total score and 7 sub-scores: Withdrawal/
social engagement, Interpersonal communication, Independence-performance,
Independence-competence, Recreation, Prosocial, and Employment/Occupation.
2.3. Procedures
All three sites involved in this longitudinal study recruited CHR individuals. Raters were
experienced research clinicians who demonstrated adequate reliability at routine reliability
checks. Gold standard post-training agreement on the critical threshold for determining
initial eligibility and subsequent conversion status based on the SIPS was excellent (kappa=
0.90). The PI or clinical psychiatrist or psychologist at each site conducted a comprehensive
clinical assessment to determine if entry criteria were met. J. Addington chaired weekly
conference calls to review criteria for all individuals admitted to the study to ensure
consensus that all participant met COPS criteria. The study protocols and informed consents
were reviewed and approved by the ethical review boards of all three study sites. All of the
data was collected at the baseline assessment.
2.4. Data analysis
To perform the mediator analysis, a neurocognitive factor was obtained from all
neurocognitive measures by using principle component factor analysis, which was deemed
appropriate for the data (Bartlett test p < 0.001, Kaiser–Meyer–Olkin index= 0.83). This
analysis generated 6 factors with eigenvalues greater than 1. However, the tests all loaded on
one factor with most of the variance being accounted for by the first factor (36.5%),
therefore only this factor was used in the mediation model. We computed two-tailed Pearson
product–moment correlations to examine relationships among neurocognition, social
cognition and functional outcome. We used Structural Equation Modeling (SEM) with
maximum likelihood estimation of the AMOS 20.0 package to estimate and test mediation
effects among the three constructs of neurocognition, social cognition and functional
outcome at the baseline assessment. SEM consists of a combination of confirmatory factor
analyses and multiple regressions to determine the relations among latent constructs. Prior to
evaluating the mediation hypothesis, we checked raw data for normality and outliers, and
replaced missing values by regression imputation. We employed confirmatory factor
analysis to ensure that the latent variable social cognition was assessed with sufficient
reliability and validity. To evaluate potential mediation effects we used 1) a basic model
postulating a direct relationship between neurocognition and functional outcome and 2) a
mediation model evaluating the strength of the indirect relationship while controlling for the
direct effect of neurocognition on functional outcome. The indirect effects in our mediation
model are the associations of social cognition with neurocognition as well as functional
outcome. We used the bootstrap method to calculate the indirect effect as simulation
research shows that bootstrapping the indirect effect tends to have the highest power and the
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best type I error control. To assess the degree to which the data fitted the structural equation
model we used the chi-square test (χ2), the comparative fit index (CFI), and the root mean-
squared error of approximation (RMSEA). A non-significant χ2, a CFI> 0.9 and an
RMSEA< 0.08 indicate a good-fitting model (Schermelleh-Engel et al., 2003). Although
larger samples are always preferable, a minimum sample of 100 has been recommended for
SEM (e.g. Kline, 1998), therefore our sample size (n=137) was adequate.
3. Results
Sample characteristics are shown in Table 1. The mean age of our sample was 19.96 (age
range 12–31). The majority of the participants were white (79%), single (94.2%), and had
completed high school (58.4%). The correlation matrix for the variables employed in the
SEM analyses is shown in Table 2. The three constructs were all associated thus meeting the
requirements for mediation. There was no association between any of these constructs and
attenuated positive symptoms.
The confirmatory factor analysis showed that all measures of social cognition made
significant contributions to their latent variable (loading range 0.33–0.76, p< 0.01; Figure 1).
The basic model (Figure 2) depicts the direct relationship between neurocognition and
functioning. This path was statistically significant (standardized coefficient β = 0.22, p <
0.01). The path from social cognition to functioning was also statistically significant (β=
0.27, p<0.05). The model explained 4.6% of the variance in functional outcome. This model
had no degrees of freedom. Probability level could not be computed, CFI =1.0, RMSEA
=0.20 (90% CI 0.08–0.36).
The mediation model intends to evaluate the strength of the indirect relationship while
controlling for the direct effect of neurocognition on functional outcome (see Figure. 3). The
direct path from neurocognition to functioning was no longer significant as soon as the
mediator was entered into the model (β = 0.02, p = 0.92). Instead, social cognition was
significantly associated with neurocognition (β = 0.80, p < 0.001). The impact of social
cognition on functioning (β=0.25) was greater than the direct impact of neurocognition
(β=0.02) but the regression weight for social cognition in the prediction of functional
outcome was not significantly different from zero at the 0.05 level (two-tailed) (p=0.23).The
model explained 7% of the variance in functional outcome. All of the model fit indices were
very good (χ2 = 4.84, df = 8, p =0.77, CFI =1.0, RMSEA = 0.0). The bootstrapping estimate
revealed the indirect effect (β =0.20, 95% CI =−0.07 to 0.52, p=0.11). The path coefficient
for the indirect effect (β=0.20) represents the change in functional outcome for every unit
change in neurocognition that is mediated through social cognition. Bootstrap approximation
with 1000 iterations yielded a percentile-based confidence interval CI =−0.06 to 0.52. As
zero is between the lower and upper bound, we cannot conclude that the indirect effect is
significantly different from zero.
4. Discussion
The aim of this study was to understand the pathway from neurocognition to functional
outcome in individuals at CHR for psychosis. Since it has been demonstrated that in
individuals with schizophrenia social cognition mediated this pathway (Schmidt et al.,
2011), we used SEM to test the hypothesis that in the CHR population the relationship
between neurocognition and functioning is mediated by social cognitive abilities. All three
constructs were associated, justifying including them in the model. Although the results of
SEM showed that the data fitted very well with the model, after controlling for mediation
effects, neurocognition and functioning were no longer significantly related. Furthermore,
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the significant association between social cognition and functioning also disappeared,
although the association between neurocognition and social cognition strengthened.
Therefore, contrary to what has been observed with individuals with schizophrenia, social
cognition did not mediate between neurocognition and functioning in this CHR sample.
It has to be noted that in the CHR population, as a group, neurocognition and social
cognition are only slightly impaired, with individuals at CHR performing at an intermediate
level between individuals with a full blown psychotic illness and healthy controls
(Addington and Barbato, 2012; Thompson et al., 2011). Therefore, it is possible that since
these impairments are attenuated, the relationship among the three constructs is weaker than
that observed in those with a full-blown psychotic illness who may have more severe
deficits. This may be a function of the fact that in samples of those at CHR probably less
than 30% will go on to develop psychosis (Fusar-Poli et al., 2012a). With a few exceptions,
the role of social cognition as a mediator has not been examined in non-psychotic samples.
In one study examining neurocognition, social cognition and functioning in schizophrenia, it
was observed that in the healthy control group, there was no mediation effect for facial
affect recognition (Addington et al., 2006b). However in a second study (Addington et al.,
2006a) it was suggested that social perception was a potential mediator between cognition
and social problem solving in both patients and controls. It is possible that the mediation
model is more relevant to explain pathways to functioning in psychotic patients and may be
a function of the specificity of the social functioning being assessed. In assessing functional
outcome, a distinction has been made between competence-based measures and attainment-
based measures. Competence measures assess functional capacity and are typically
performance based simulations or role-plays of activities required for daily living whereas
attainment-based measures focus on what an individual has accomplished and are assessed
by either obtaining an individual’s subjective sense of their functioning or a more objective
measure of their functioning. Generally, functional capacity is more likely to be affected by
factors such as neurocognition (Horan et al., 2013). This may be the reason why in the two
studies with healthy controls mediation was only observed with a competence-based
measure of outcome. Interestingly, once social cognition was included in the mediation
model, the strength of the relationship between neurocognition and social cognition
increased significantly suggesting that even in this early stage of psychosis the two concepts
are significantly associated.
There are several limitations to this study. First we only had one measure of functional
outcome, the SFS, which is an attainment-based measure of functional outcome. This may
have increased the variance in functional outcome and possibly led to a reduced path
coefficient between social cognition and functional outcome. Secondly, we did assess two
domains of social cognition; however, we had three measures of affect recognition, but only
one measure of theory of mind. Thirdly, our measures of social cognition and the SFS were
developed for adult populations and therefore may not be completely appropriate for such a
young sample. More recently other scales have been designed to assess social and role
functioning in this population (Cornblatt et al., 2007). The strength of this study is that we
used a comprehensive and well validated cognitive battery and that the sample was
antipsychotic free.
In conclusion, unlike what has been observed with psychotic patients, social cognition does
not seem to mediate the pathway from neurocognition to functional outcome when assessed
with a measure of social attainment in individuals at CHR for psychosis. Future studies may
need to use a variety of approaches to assess functional outcome and to consider other
interacting and intervening variables as the pathway through which neurocognition impacts
functional outcome is likely highly complex.
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Confirmatory factor analysis model.
**p<0.01; ***p<0.001. Circles represent unobserved latent variables. Rectangles represent
observed measured variables. Values are standardized path coefficients. BCTOTAL:
Reading the Mind in the Eyes Test, FEITTOTL: Facial Emotion Identification Test,
FEDTOTL: Facial Emotion Discrimination Test, AP_TOTL: Affective prosody Test.
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** p<0.01. Rectangles represent observed measured variables.
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*** p<0.001 Circles represent unobserved latent variables. Rectangles represent observed
measured variables. Values are standardized path coefficients. BCTOTAL: Reading the
Mind in the Eyes Test, FEITTOTL: Facial Emotion Identification Test, FEDTOTL: Facial
Emotion Discrimination Test, AP_TOTL: Affective prosody Test.
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Age – Mean (SD) 19.96 (4.67)
Race – %
   White 79%
   Black 7.3%
   Asian 7.3%
   Hawaiian 0.7%
   Mixed 5.1%
Marital status – %
   Married 5.1%
   Separated 0.7%
   Never Married 94.2%
Education – %
   Did not complete High School 41.6%
   Completed High School 10.2%
   College or University Degree 43.8%
   Post graduate Degree 4.4%
Symptoms – Mean (SD)
   SOPS Positive 10.88 (3.04)
   SOPS Negative 8.04 (5.78)
Social cognition– Mean (SD)
   Affective Prosody 44.31 (7.00)
   Eyes Test 25.16 (4.94)
   FEDT 25.67 (1.98)
   FEIT 12.74 (2.40)
Social Functioning Scale– Mean (SD) 127.50 (19.14)
SOPS: Structured Interview for Prodromal Symptoms; FEDT: Facial Emotion Discrimination Test; FEIT: Facial Emotion Identification Test;
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